Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience Ionescu, F., Ajayi, E., Leach, A., Alsina, M., Bejanyan, N., Castaneda-Puglianini, O., Elmariah, H., Freeman, C. L., Hansen, D. K., Jain, M. D., Khimani, F., Lazaryan, A., Liu, H. D., Locke, F. L., McIver, B., Mishra, A., Nieder, M., Ochoa, J., Perez, L., Pidala, J., Baluch, A., Klinkova, O., Quilitz, R., Nishihori, T., Faramand, R. ELSEVIER. 2022: 10488-10490View details for DOI 10.1182/blood-2022-170337
View details for Web of Science ID 000893230303218